Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...
Nov 4, 2021
0
1
Biotechnology company Novavax said Monday that Indonesia has given the world's first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current shots.
Nov 1, 2021
0
3
Medical workers at Bulgaria's main emergency hospital are waging an uphill battle as a surge in coronavirus cases has overwhelmed the country's ailing health care system.
Oct 29, 2021
0
26
Slovakia extended tight coronavirus restrictions to more parts of the country on Monday as the latest surge of infections intensified.
Oct 25, 2021
0
5
People in Estonia no longer can use negative test results to obtain the coronavirus certificates needed to attend sporting events, movie showings, indoor public meetings and other events.
Oct 25, 2021
0
18
Since its emergence in March 2021, the Delta variant has rapidly become predominant across the European Union. More than 99% of newly reported cases are attributed to this variant, according to the European Centre for Disease ...
Oct 21, 2021
0
3
Latvia plunged back into lockdown on Thursday with non-essential shops closed and cinema, theatres and hairdressers shutting down for a month in a bid to break the world's worst COVID rate.
Oct 21, 2021
0
3
Franco-Austrian biotech lab Valneva announced Monday positive results from clinical trials of its COVID vaccine candidate, a month after the UK government terminated a supply deal with the company.
Oct 18, 2021
1
40
Pharmaceutical company Pfizer and biotechnology company BioNTech said Friday they have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union. If EU regulators agree, it would ...
Oct 15, 2021
0
5
Germany's CureVac said Tuesday it is no longer seeking European regulatory approval for its coronavirus vaccine, and will focus instead on a more promising second-generation jab.
Oct 12, 2021
0
3
